Impact of FTO Gene Variation on Body Composition, Lipid Profile, Insulin Resistance, Advanced Glycation End-Products and Ghrelin Levels in Response to Hypocaloric, Protein Rich-Diet
Launched by KHYBER MEDICAL UNIVERSITY PESHAWAR · May 17, 2024
Trial Information
Current as of March 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1Overweight (BMI ≥ 25kg/m2) and obese (BMI ≥ 30kg/m2) individuals.
- • Both genders.
- • Age 18-50 years.
- Exclusion Criteria:
- • Children, pregnant and lactating women
- • Individuals taking medication for weight loss or undergoing any other weight loss dietary intervention.
- • Individuals having lost more than 5 pounds in the past three-month period.
- • Patients with any psychiatric disorders, heart, liver, kidney disease, diabetes or abnormal thyroid function.
About Khyber Medical University Peshawar
Khyber Medical University Peshawar is a leading academic institution dedicated to advancing medical education, research, and healthcare in Pakistan. With a commitment to excellence, the university plays a pivotal role in fostering clinical research initiatives that aim to improve patient outcomes and public health. Through its robust infrastructure and collaboration with local and international partners, Khyber Medical University Peshawar conducts innovative clinical trials that adhere to rigorous ethical standards and regulatory guidelines, contributing to the global body of medical knowledge and the development of effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Kpk, Pakistan
Peshawar, Kpk, Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
